Identifying "at-risk" patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections

被引：16
作者：
Abdul-Aziz, Mohd H. [1 ,2 ]
Lipman, Jeffrey [1 ,3 ]
Roberts, Jason A. [1 ,3 ,4 ,5 ]
机构：
[1] Univ Queensland, Ctr Clin Res UQCCR, Fac Med, Royal Brisbane & Womens Hosp, Bldg 71-918, Brisbane, Qld 4029, Australia
[2] Int Islamic Univ Malaysia, Sch Pharm, Kuantan, Malaysia
[3] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[4] Univ Queensland, Sch Pharm, Ctr Translat Antiinfect Pharmacodynam, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
来源：
CRITICAL CARE | 2017年 / 21卷
基金：
英国医学研究理事会;
关键词：
Augmented renal clearance; Critically ill; Meropenem; Pharmacokinetic; Pharmacodynamic; Risk assessment tool; MEROPENEM;
D O I：
10.1186/s13054-017-1871-2
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：3
相关论文
共 15 条
[1]   Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development [J].
Abdul-Aziz, Mohd H. ;
Lipman, Jeffrey ;
Mouton, Johan W. ;
Hope, William W. ;
Roberts, Jason A. .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (01) :136-153
[2]   A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance [J].
Baptista, Joao Pedro ;
Udy, Andrew A. ;
Sousa, Eduardo ;
Pimentel, Jorge ;
Wang, Lisa ;
Roberts, Jason A. ;
Lipman, Jeffrey .
CRITICAL CARE, 2011, 15 (03)
[3]   Comparison of different equations to assess glomerular filtration in critically ill patients [J].
Carlier, Mieke ;
Dumoulin, Alexander ;
Janssen, Alexander ;
Picavet, Sven ;
Vanthuyne, Steve ;
Van Eynde, Ria ;
Vanholder, Raymond ;
Delanghe, Joris ;
Schoenmakere, Gert De ;
De Waele, Jan J. ;
Hoste, Eric A. J. .
INTENSIVE CARE MEDICINE, 2015, 41 (03) :427-435
[4]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[5]   Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study [J].
Ehmann, Lisa ;
Zoller, Michael ;
Minichmayr, Iris K. ;
Scharf, Christina ;
Maier, Barbara ;
Schmitt, Maximilian V. ;
Hartung, Niklas ;
Huisinga, Wilhelm ;
Vogeser, Michael ;
Frey, Lorenz ;
Zander, Johannes ;
Kloft, Charlotte .
CRITICAL CARE, 2017, 21
[6]   Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams [J].
Goncalves-Pereira, Joao ;
Povoa, Pedro .
CRITICAL CARE, 2011, 15 (05)
[7]   Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study [J].
Huttner, Angela ;
Von Dach, Elodie ;
Renzoni, Adriana ;
Huttner, Benedikt D. ;
Affaticati, Mathieu ;
Pagani, Leonardo ;
Daali, Yousef ;
Pugin, Jerome ;
Karmime, Abderrahim ;
Fathi, Marc ;
Lew, Daniel ;
Harbarth, Stephan .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (04) :385-392
[8]   Mortality Related to Severe Sepsis and Septic Shock Among Critically III Patients in Australia and New Zealand, 2000-2012 [J].
Kaukonen, Kirsi-Maija ;
Bailey, Michael ;
Suzuki, Satoshi ;
Pilcher, David ;
Bellomo, Rinaldo .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (13) :1308-1316
[9]   Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections [J].
Li, Chonghua ;
Du, Xiaoli ;
Kuti, Joseph L. ;
Nicolau, David P. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (05) :1725-1730
[10]   Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients [J].
Mattioli, Francesca ;
Fucile, Carmen ;
Del Bono, Valerio ;
Marini, Valeria ;
Parisini, Andrea ;
Molin, Alexandre ;
Zuccoli, Maria Laura ;
Milano, Giulia ;
Danesi, Romano ;
Marchese, Anna ;
Polillo, Marialuisa ;
Viscoli, Claudio ;
Pelosi, Paolo ;
Martelli, Antonietta ;
Di Paolo, Antonello .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (07) :839-848
12